Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?

Viking Therapeutics (VKTX 5.77%) shares soared more than 120% in one trading session last month as investors bet on its ability to win in the billion-dollar weight-loss drug market -- or attract a buyer. The biotech company announced positive clinical trial results for its weight-loss candidate that works in the same way as a drug sold by pharma giant Eli Lilly (LLY 2.80%).Patients and investors are excited about this class of drug thanks to impressive results in clinical trials and in the real world. And d ...